Drug, dick york, the therapy the drug, the ce, the therapy. Judy all that and more on tonights pbs newshour. Major funding for the pbs newshour has been provided by with fidelity wealth management, a dedicated advisor can tailor advice and recommendations to your life. That is fidelity wealth management. Consumer cellular. Johnson johnson. Financial Services Firm raymond james. Bmsf. The william and flora hewlett foundation. Advancing ideas and supporting institutions to promote a better world. The chance zuckerberg the chanzuckerberg initiative. At czi. Org. And, with the ongoing suppor of these individuals and institutions. This program was made possible by the corporation for public broadcasting in support from viewers like you. Judy the covid19 paemic in the u. S. Is generating both t despair and hoight. Total infections have soared over the 11 million mark nationwide, but there is also progress in the effort to stop the virus. William brangham begins our coverage. William a new we
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 202,832 shares of Moderna stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $148.34, for a total transaction of $30,088,098.88. Following the completion of the sale, the director now directly owns 1,528,557 shares of the company’s […]
Humankind Investments LLC raised its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 32.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,636 shares of the company’s stock after buying an additional 1,882 shares during the period. Humankind Investments LLC’s holdings in […]
Advanced Portfolio Management LLC acquired a new stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 6,014 shares of the company’s stock, valued at approximately $598,000. Other hedge funds have also recently bought and sold shares of […]
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $151.25, for a total value of $2,268,750.00. Following the transaction, the director now directly owns 1,946,931 shares of the company’s stock, valued […]